182 related articles for article (PubMed ID: 18536689)
1. A new path to the cancer epigenome.
Richon VM
Nat Biotechnol; 2008 Jun; 26(6):655-6. PubMed ID: 18536689
[No Abstract] [Full Text] [Related]
2. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
[TBL] [Abstract][Full Text] [Related]
3. The role of SATB1 in breast cancer pathogenesis.
Iorns E; Hnatyszyn HJ; Seo P; Clarke J; Ward T; Lippman M
J Natl Cancer Inst; 2010 Aug; 102(16):1284-96. PubMed ID: 20595686
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer bone metastasis: molecular basis of tissue tropism.
Kang Y
J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):379-80. PubMed ID: 15758269
[No Abstract] [Full Text] [Related]
5. Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.
España L; Martín B; Aragüés R; Chiva C; Oliva B; Andreu D; Sierra A
Am J Pathol; 2005 Oct; 167(4):1125-37. PubMed ID: 16192647
[TBL] [Abstract][Full Text] [Related]
6. Is SATB1 a master regulator in breast cancer growth and metastasis?
Zheng J
Womens Health (Lond); 2008 Jul; 4(4):329-32. PubMed ID: 19072498
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase Cgamma1 is required for metastasis development and progression.
Sala G; Dituri F; Raimondi C; Previdi S; Maffucci T; Mazzoletti M; Rossi C; Iezzi M; Lattanzio R; Piantelli M; Iacobelli S; Broggini M; Falasca M
Cancer Res; 2008 Dec; 68(24):10187-96. PubMed ID: 19074886
[TBL] [Abstract][Full Text] [Related]
8. Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model.
Rhee DK; Park SH; Jang YK
Genomics; 2008 Dec; 92(6):419-28. PubMed ID: 18804527
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A
Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733
[TBL] [Abstract][Full Text] [Related]
11. Distinct karyotypes in three breast cancer cell lines --21PTCi, 21NTCi, and 21MT-1 --derived from the same patient and representing different stages of tumor progression.
Xu J; Souter LH; Chambers AF; Rodenhiser DI; Tuck AB
Cancer Genet Cytogenet; 2008 Oct; 186(1):33-40. PubMed ID: 18786440
[TBL] [Abstract][Full Text] [Related]
12. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
13. A "bone" fide predictor of metastasis? Predicting breast cancer metastasis to bone.
Kominsky SL; Davidson NE
J Clin Oncol; 2006 May; 24(15):2227-9. PubMed ID: 16636338
[No Abstract] [Full Text] [Related]
14. MicroRNA-10b and breast cancer metastasis.
Gee HE; Camps C; Buffa FM; Colella S; Sheldon H; Gleadle JM; Ragoussis J; Harris AL
Nature; 2008 Oct; 455(7216):E8-9; author reply E9. PubMed ID: 18948893
[No Abstract] [Full Text] [Related]
15. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
16. Genes that mediate breast cancer metastasis to lung.
Minn AJ; Gupta GP; Siegel PM; Bos PD; Shu W; Giri DD; Viale A; Olshen AB; Gerald WL; Massagué J
Nature; 2005 Jul; 436(7050):518-24. PubMed ID: 16049480
[TBL] [Abstract][Full Text] [Related]
17. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
Shi M; Guo N
Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]